Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection.
about
Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infectionHepatitis B and A vaccination in HIV-infected adults: A reviewImmunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals.GM-CSF Fails to Improve Immune Responses to Booster Hepatitis B Vaccination in HIV-Infected Individuals.Encapsulated cellular implants for recombinant protein delivery and therapeutic modulation of the immune system.Dendritic cell fusion vaccines for cancer immunotherapy.Effects of Oral Levamisole as an Adjuvant to Hepatitis B Vaccine in HIV/ AIDS Patients: A Randomized Controlled Trial.Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth.Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations.Construction and expression of a recombinant eukaryotic expression plasmid containing the preS1-preS2-S genes of hepatitis B virus and the granulocyte-macrophage colony stimulating factor gene: A study of its immunomodulatory effects.Factors associated with seroconversion after standard dose hepatitis B vaccination and high-dose revaccination among HIV-infected patients.Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling.Hepatitis B virus vaccination in HIV-infected people: A review.Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses.Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
P2860
Q24193121-EF2781DD-CF81-4DD5-90B3-828998C5C482Q26799782-AD067D06-B8AC-4FCA-A90B-B6C837DF05C3Q33623763-06545605-6C7D-46A1-B091-292DE6938FC7Q34077801-51D871DE-6181-4FF1-8981-D77559FDBDA9Q34147433-7DF8E4D0-DEBD-4447-AC0F-C7631A90BD0DQ34405008-1948F737-F8C7-480B-B550-5CFCB8680068Q34850890-3AB0D352-40AC-4F23-B71A-0FF4A5D9FFDCQ35441596-40016516-EF85-4AAA-83DC-DF90458D84A1Q35723422-A6D230CA-735D-4427-B517-803A220A6D4BQ36150517-DBE0D747-98C9-459E-AD49-59EE002B3282Q36329345-797FF64C-0C33-44F9-9614-09F61CBCC0BAQ37407229-1EF0573B-ECC0-41D4-88A2-FCA26AC46E10Q37587663-EA1EFADF-C1F2-4D88-86E7-5D526C1E389AQ37641023-8EF80454-D198-4C8A-A411-A447685A2F7BQ37829113-31495943-E2CC-4CF7-A4E8-2DC352929B4DQ37884343-8475C0DF-EE9B-4904-8294-C16D9DF36C7FQ39166033-251FE669-93F2-4644-8D6B-F442DFFF47B7Q42059101-AA41F2F4-1BBD-4148-AD8C-85A065123CCAQ45401512-82476E65-9CF4-4C5D-A357-5538CC287B16
P2860
Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Efficacy of granulocyte-macrop ...... n patients with HIV infection.
@en
Efficacy of granulocyte-macrophage colony-stimulating factor
@nl
type
label
Efficacy of granulocyte-macrop ...... n patients with HIV infection.
@en
Efficacy of granulocyte-macrophage colony-stimulating factor
@nl
prefLabel
Efficacy of granulocyte-macrop ...... n patients with HIV infection.
@en
Efficacy of granulocyte-macrophage colony-stimulating factor
@nl
P2093
P1433
P1476
Efficacy of granulocyte-macrop ...... n patients with HIV infection.
@en
P2093
Iara J de Messias-Reason
Maria das Graças Sasaki
Roberto Foccacia
P304
P356
10.1016/S0264-410X(03)00500-0
P407
P577
2003-11-01T00:00:00Z